Top news
Regulatory News

search

topic
content
Pharmaceutical & Cosmetic
Xianglei Tangzu Cream approved with conditions for marketing by China NMPA
    Pubtime: 2023-12-22

  Recently, the natural products Category 1.1 innovative drug Xianglei Tangzu Cream (Fespixon Cream) of Oneness Biotech Co., Ltd. was approved for marketing with conditions by China NMPA. This drug is used for treating Wagner grade 1 diabetic foot ulcer (DFU) with wound cross-sectional area less than 25cm2 after debridement. The marketing of this drug provides a new treatment option for patients with Wagner grade 1 DFU.

Produced By CMS 网站群内容管理系统 publishdate:2024/03/27 01:52:38